REGENXBIO vs VectorY
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy
389 employees · est. 2008 · Rockville, United States
VectorY
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions
114 employees · est. 2020 · Amsterdam, The Netherlands
REGENXBIO is the older company (2008 vs 2020); REGENXBIO is the larger of the two.
Side-by-Side Comparison
| Metric | REGENXBIO | VectorY |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2020 |
| Headquarters | ||
| Headquarters | Rockville, United States | Amsterdam, The Netherlands |
| Employees | ||
| Employees | 389 larger | 114 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | IPO | Series A |
| Total Funding | ||
| Total Funding | $1.58B | $160.00M |
| Funding Rounds | ||
| Funding Rounds | 17 | 2 |
| Services | ||
| Services | Developing Gene Therapy Candidates, Clinical Trials, In-house Manufacturing, Research and Development | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with Retinal Diseases, Patients with Genetic Disorders, Healthcare Providers, Pharmaceutical Partners | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Gene TherapyAAV TherapeuticsBiopharmaceuticalsRetinal DiseasesRare DiseasesAAV Vectors +8 | Gene TherapyAntibody TherapyVectorized AntibodiesCNS DisordersSomatic DisordersMuscle Diseases +7 |
| Website | ||
| Website | regenxbio.com | vectorytx.com |
About REGENXBIO
REGENXBIO, founded in 2008, is a clinical-stage biotechnology company based in the United States known for its pioneering work in AAV Therapeutics, a promising class of gene therapy medicines. The company is actively advancing a robust pipeline targeting retinal and rare diseases with products like...
About VectorY
VectorY is a promising player in the Biotechnology industry, leveraging the therapeutic potential of antibodies and gene therapy to address large disease areas with high unmet medical needs. Founded in August 2020 and based in the Amsterdam Science Park, this fully integrated gene therapy company is...
Also comparing in this category
Comparing more than these two?
Get REGENXBIO, VectorY and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does REGENXBIO compare?
A PDF of REGENXBIO and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare REGENXBIO with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at REGENXBIO on 9 Jun 2026, and VectorY on 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
